FECH Expression Correlates with the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma

Table 3

Results of gene ontology enrichment analysis.

Ontology	ID	Description	Gene Ratio	Bg Ratio	P value	P. adjust	Q value
BP	GO:0002526	Acute inflammatory response	21/96	220/18670	4.30e−21	6.40e−18	5.33e−18
BP	GO:0006953	Acute-phase response	10/96	47/18670	3.53e−14	2.63e−11	2.19e−11
BP	GO:0072376	Protein activation cascade	12/96	198/18670	4.16e−10	1.55e−07	1.29e−07
BP	GO:2000257	Regulation of protein activation cascade	10/96	116/18670	4.17e−10	1.55e−07	1.29e−07
BP	GO:0006956	Complement activation	11/96	175/18670	1.58e−09	4.71e−07	3.93e−07
CC	GO:0072562	Blood microparticle	15/101	147/19717	1.02e−15	1.56e−13	1.31e−13
CC	GO:0034364	High-density lipoprotein particle	9/101	26/19717	4.90e−15	3.78e−13	3.17e−13
CC	GO:0034358	Plasma lipoprotein particle	9/101	37/19717	1.86e−13	7.18e−12	6.03e−12
CC	GO:1990777	Lipoprotein particle	9/101	37/19717	1.86e−13	7.18e−12	6.03e−12
CC	GO:0032994	Protein-lipid complex	9/101	39/19717	3.15e−13	9.70e−12	8.15e−12
MF	GO:0043178	Alcohol binding	7/94	85/17697	3.35e−07	7.77e−05	6.03e−05
MF	GO:0017127	Cholesterol transporter activity	4/94	18/17697	2.16e−06	1.44e−04	1.12e−04
MF	GO:0120020	Intermembrane cholesterol transfer activity	4/94	18/17697	2.16e−06	1.44e−04	1.12e−04
MF	GO:0120015	Intermembrane sterol transfer activity	4/94	19/17697	2.72e−06	1.44e−04	1.12e−04
MF	GO:0034987	Immunoglobulin receptor binding	6/94	76/17697	3.10e−06	1.44e−04	1.12e−04
KEGG	hsa04979	Cholesterol metabolism	5/38	50/8076	3.19e−06	2.78e−04	2.52e−04
KEGG	hsa03320	PPAR signaling pathway	4/38	78/8076	4.63e−04	0.019	0.017
KEGG	hsa04610	Complement and coagulation cascades	4/38	85/8076	6.42e−04	0.019	0.017
KEGG	hsa04975	Fat digestion and absorption	3/38	43/8076	0.001	0.023	0.021
KEGG	hsa04977	Vitamin digestion and absorption	2/38	24/8076	0.006	0.097	0.088